OPT Machine Vision Tech (688686) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
22 Oct, 2026Executive summary
9M 2024 revenue fell 13.32% YoY to RMB 733.26m; net income attributable to shareholders declined 35.58% to RMB 131.94m.
Q3 revenue decreased 6.96% YoY to RMB 210.96m; net income attributable to shareholders fell 40.32% to RMB 18.58m.
Q3 financial statements were unaudited.
Financial highlights
9M adjusted net income, excluding non-recurring items, was RMB 121.38m, down 33.37% YoY; Q3 adjusted net income was RMB 24.27m, up 2.41%.
9M operating profit was RMB 133.23m versus RMB 220.31m in the prior-year period; net profit was RMB 131.94m versus RMB 204.80m.
9M basic and diluted EPS were RMB 1.0794, down 35.64% YoY.
9M operating cash flow was RMB 17.82m, down 86.79% YoY.
Segment performance
Revenue declined amid lower overall sales; management attributed Q3 net income pressure to lower revenue and higher expenses for new-customer development and new-product development.
Latest events from OPT Machine Vision Tech
- Weak end markets cut H1 earnings; sustained R&D and product expansion underpin the response.688686
H1 2024 - Profit contracted as lithium and 3C demand softened; semiconductor and automotive sales surged.688686
H2 2024 - Q1 revenue and earnings declined as R&D intensity rose and operating cash flow stayed negative.688686
Q1 2024 - H1 growth accelerated on industrial AI and battery demand; FY revenue target is at least 20%.688686
H1 2025 - Revenue grew 39% as AI, lithium batteries and overseas sales advanced; 2026 target is at least 25%.688686
H2 2025 - Revenue grew 18.09%; adjusted net income rose 11.40% as operating cash flow turned positive.688686
Q1 2025 - Revenue grew 32.46%, while strategic stocking pulled operating cash flow to negative RMB 168.12m.688686
H1 2026 - Q3 revenue surged 56.33% as industrial AI, 3C and lithium-battery demand lifted growth.688686
Q3 2025 - Revenue grew 33.51% as semiconductor, automotive and Industrial AI solutions accelerated.688686
Q1 2026